Nov 18, 2025
Omar Abdel-Wahab, MD, Chair, Pharmacology Program, Department of Medicine, Sloan Kettering Institute, New York City. For being a pioneer in uncovering genetic causes for diverse forms of blood cancers and utilizing this information to develop therapeutic approaches to transform clinical care. His laboratory has made pivotal insights into BTK inhibitor resistance mechanisms and the role of RNA splicing factor mutations in leukemogenesis.